Ren‐Bo Ding
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacological Effects of Natural Compounds
Papers in
-
- Natural product bioactivities and synthesis 3
- Histone Deacetylase Inhibitors Research 3
- Ginseng Biological Effects and Applications 3
- Receptor Mechanisms and Signaling 2
- Nicotinic Acetylcholine Receptors Study 2
-
- Liver Disease Diagnosis and Treatment 3
- Autophagy in Disease and Therapy 3
- Co-authors
- Jiaolin Bao (14 shared papers)Chu‐Xia Deng (1 shared paper)Jian‐Bo Wan (7 shared papers)Chengwei He (5 shared papers)Ke Tian (2 shared papers)Huanxing Su (4 shared papers)Yun Jiang (1 shared paper)Yitao Wang (1 shared paper)
- Journals
- The American Journal of Chinese Medicine (3 papers)Molecules (3 papers)Journal of Pharmaceutical and Biomedical Analysis (1 paper)European Journal of Medicinal Chemistry (1 paper)One Health (1 paper)
- Partner nations
- MacaoChinaUnited States
In The Last Decade
Ren‐Bo Ding
17 papers receiving 698 citations
Peers
Comparison fields: 5 of 80
- Geriatrics and Gerontology 80
- Pharmacology 104
- Pathology and Forensic Medicine 129
- Epidemiology 209
- Endocrinology, Diabetes and Metabolism 84
Countries citing papers authored by Ren‐Bo Ding
This map shows the geographic impact of Ren‐Bo Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ren‐Bo Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ren‐Bo Ding more than expected).
Fields of papers citing papers by Ren‐Bo Ding
This network shows the impact of papers produced by Ren‐Bo Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ren‐Bo Ding. The network helps show where Ren‐Bo Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Ren‐Bo Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 296 | |
| 2 | 2012 | 122 | |
| 3 | 2015 | 85 | |
| 4 | 2016 | 60 | |
| 5 | 2017 | 29 | |
| 6 | 2015 | 25 | |
| 7 | 2022 | 23 | |
| 8 | 2023 | 16 | |
| 9 | 2018 | 15 | |
| 10 | 2024 | 8 | |
| 11 | 2024 | 6 | |
| 12 | 2024 | 4 | |
| 13 | 2024 | 4 | |
| 14 | 2025 | 3 | |
| 15 | 2014 | 3 | |
| 16 | 2024 | 2 | |
| 17 | Research and analysis of the consumption market of dairy products in Nanjing district. | 2010 | 1 |
| 18 | 2024 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2024 | 0 |
About Ren‐Bo Ding
Ren‐Bo Ding is a scholar working on Molecular Biology, Epidemiology, Plant Science, Pharmacology and Genetics, having authored 20 papers that have together received 702 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (3 papers), Phytochemistry and Biological Activities (3 papers), Natural product bioactivities and synthesis (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Ginseng Biological Effects and Applications (3 papers), Autophagy in Disease and Therapy (3 papers), Receptor Mechanisms and Signaling (2 papers) and Nicotinic Acetylcholine Receptors Study (2 papers). The work is most often cited by research in Geriatrics and Gerontology (80 citations), Pharmacology (104 citations), Pathology and Forensic Medicine (129 citations), Epidemiology (209 citations) and Endocrinology, Diabetes and Metabolism (84 citations). Ren‐Bo Ding has collaborated with scholars based in Macao, China and United States. Frequent co-authors include Jiaolin Bao, Chu‐Xia Deng, Jian‐Bo Wan, Chengwei He, Ke Tian, Huanxing Su, Yun Jiang, Yitao Wang, Hu Y and Yiwei Cao. Their work appears in journals such as The American Journal of Chinese Medicine, Molecules, Journal of Pharmaceutical and Biomedical Analysis, European Journal of Medicinal Chemistry and One Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.